These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 32425293)

  • 21. Re: Profile of specific antibodies to SARS-CoV-2: The first report.
    Zeng Z; Chen L; Pan Y; Deng Q; Ye G; Li Y; Wang X
    J Infect; 2020 Jul; 81(1):e80-e81. PubMed ID: 32283140
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany.
    Rexroth U; Hamouda O; Hanefeld J; Ruehe B; Wieler LH; Schaade L
    Euro Surveill; 2020 Jun; 25(23):. PubMed ID: 32553063
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Iwen PC; Stiles KL; Pentella MA
    Am J Clin Pathol; 2020 Apr; 153(5):567-570. PubMed ID: 32190890
    [No Abstract]   [Full Text] [Related]  

  • 24. Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria.
    Ahamed Mim M; Naznin Rakhi N; Saha O; Rahaman MM
    Pathog Glob Health; 2020 May; 114(4):168-169. PubMed ID: 32407189
    [No Abstract]   [Full Text] [Related]  

  • 25. From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy.
    Wang HJ
    Fa Yi Xue Za Zhi; 2020 Feb; 36(1):1-3. PubMed ID: 32198983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19: Should sexual practices be discouraged during the pandemic?
    Yin Z
    J Am Acad Dermatol; 2020 Aug; 83(2):e149. PubMed ID: 32360858
    [No Abstract]   [Full Text] [Related]  

  • 27. How we treat patients with lung cancer during the SARS-CoV-2 pandemic.
    Provencio M; Ruano-Raviña A
    ESMO Open; 2020 May; 4(Suppl 2):e000785. PubMed ID: 32409297
    [No Abstract]   [Full Text] [Related]  

  • 28. Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.
    Yeo WS; Ng QX; Tan KY
    Am J Clin Pathol; 2020 Jul; 154(2):278-279. PubMed ID: 32472673
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnosis and Management of First Case of COVID-19 in Canada: Lessons Applied From SARS-CoV-1.
    Marchand-Senécal X; Kozak R; Mubareka S; Salt N; Gubbay JB; Eshaghi A; Allen V; Li Y; Bastien N; Gilmour M; Ozaldin O; Leis JA
    Clin Infect Dis; 2020 Nov; 71(16):2207-2210. PubMed ID: 32147731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration for carrying SARS-CoV-2 in COVID-19 patients.
    Du X; Yu X; Li Q; Li X; Qin T; Luo Q; Wang M; Jiang M; Bai L; Wang X; Pan Y
    J Infect; 2020 Jul; 81(1):e78-e79. PubMed ID: 32283161
    [No Abstract]   [Full Text] [Related]  

  • 31. Frailty assessment in the COVID-19 pandemic.
    Ng Cheong Chung KJ; Kunadian V
    J Investig Med; 2020 Oct; 68(7):1300-1301. PubMed ID: 32747401
    [No Abstract]   [Full Text] [Related]  

  • 32. Community-Acquired Respiratory Viruses in Oncology: Lessons to Be Learnt from the SARS-CoV-2 Pandemic.
    von Lilienfeld-Toal M
    Oncol Res Treat; 2020; 43(6):262-263. PubMed ID: 32408304
    [No Abstract]   [Full Text] [Related]  

  • 33. A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet.
    Liu L; Quan J; Lv J; Long S; Hu W; Zhuge H; Zhou Z; Zhao D
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32283138
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical Trials during the SARS-CoV-2 Pandemic.
    Warnock DG
    Nephron; 2020; 144(5):248-250. PubMed ID: 32289798
    [No Abstract]   [Full Text] [Related]  

  • 35. Duration of SARS-CoV-2 viral RNA in asymptomatic carriers.
    Yan X; Han X; Fan Y; Fang Z; Long D; Zhu Y
    Crit Care; 2020 May; 24(1):245. PubMed ID: 32448332
    [No Abstract]   [Full Text] [Related]  

  • 36. SARS-CoV-2 pandemic in the western world: the lessons learned.
    Castelli F
    J R Coll Physicians Edinb; 2020 Jun; 50(2):110-111. PubMed ID: 32568277
    [No Abstract]   [Full Text] [Related]  

  • 37. SARS-CoV, Mers-CoV and COVID-19: what differences from a dermatological viewpoint?
    Rongioletti F
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e581-e582. PubMed ID: 32526085
    [No Abstract]   [Full Text] [Related]  

  • 38. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19.
    Sharun K; Dhama K; Patel SK; Pathak M; Tiwari R; Singh BR; Sah R; Bonilla-Aldana DK; Rodriguez-Morales AJ; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2020 May; 19(1):23. PubMed ID: 32473642
    [No Abstract]   [Full Text] [Related]  

  • 39. Mental health and the SARS-CoV-2 pandemic.
    Crespo-Facorro B
    Rev Psiquiatr Salud Ment (Engl Ed); 2020; 13(2):55-56. PubMed ID: 32409249
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19: ICU delirium management during SARS-CoV-2 pandemic-pharmacological considerations.
    Andrews LJ; Benken ST
    Crit Care; 2020 Jun; 24(1):375. PubMed ID: 32576234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.